Biomanufacturing

Biomanufacturing applies biological processes to produce materials, chemicals, fuels, and medicines at industrial scale, using engineered organisms, cell-free systems, and fermentation technology. The sector represents the industrial application of synthetic biology and bioengineering, scaling laboratory discoveries into commercially viable production processes. Biomanufacturing is essential for producing biologics (monoclonal antibodies, cell therapies, gene therapies, vaccines), bio-based chemicals (replacing petrochemical feedstocks), and novel materials (spider silk proteins, leather alternatives, sustainable fuels). The global biomanufacturing market exceeds $400 billion, with biopharmaceutical manufacturing comprising the largest segment. The sector faces a fundamental scaling challenge: biological processes that work at laboratory scale often behave differently at industrial scale, requiring years of process development and hundreds of millions in capital for manufacturing facility construction.